glp-1 news Science's 2023 Breakthrough: Agonists Show Promise Against Obesity-Associated Disease GLP-1 Antagonists Increase Plan Drug
Description
SC and oral formulations evaluated
doi: 10.1016/j.appet.2008.12.003, 49 GearhardtA
Because individual responses vary, the clinicians experience and the patients symptom profile guide titration
Front to back, always
Archived from the original on 19 January 2024
For example, using a mouse model of Huntingtons disease, they found that exendin-4 reduces the accumulation of the mutant huntingtin protein, which is implicated in the diseases onset and progression
